4//SEC Filing
Omrix Biopharmaceuticals, Inc. 4
Accession 0001209191-07-034346
CIK 0001349426operating
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 11:05 AM ET
Size
7.6 KB
Accession
0001209191-07-034346
Insider Transaction Report
Form 4
PRICE FREDRIC D
Director
Transactions
- Award
Common Stock, par value $0.01 per share
2007-05-31+2,000→ 7,000 total - Award
Stock Option (Right to Buy)
2007-05-31+20,000→ 0 totalExercise: $33.10Exp: 2017-05-31→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The shares were issued as a restricted stock grant and vest on May 31, 2009.
- [F2]The shares underlying this stock option become vested and exercisable in four equal installments of 25% each on the following dates: May 31, 2008, May 31, 2009, May 31, 2010 and May 31, 2011.
Documents
Issuer
Omrix Biopharmaceuticals, Inc.
CIK 0001349426
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001349426
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 11:05 AM ET
- Size
- 7.6 KB